Dr. Maria L. Padilla, MD

Dr. Padilla practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Padilla's NPI, 1285652024, was assigned on July 18, 2006. Dr. Padilla graduated from Icahn School Of Medicine At Mount Sinai in 1975. Dr. Padilla holds New York license 127779.

Dr. Padilla's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Padilla also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Padilla's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. Dr. Padilla is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Padilla to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Padilla practices, 5 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Padilla's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Padilla is board certified in internal medicine by the American Board of Internal Medicine. Dr. Padilla is licensed in New York.

Dmand AI lists asthma, bronchitis, chronic lung disease, chronic obstructive pulmonary disease (COPD), hypersomnia, pneumonia, pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Padilla treats.

CMS data shows 1,817 Medicare services from Dr. Padilla across 8 procedure codes in 2024, for 290 Medicare patients. Medicare paid $83,243 for them.

CMS counts 290 Medicare patients who saw Dr. Padilla in 2024. The largest group is 65 to 74, with 115 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Padilla's median patient age at 71, with 57% women.

In 2024, Dr. Padilla wrote 1,355 Medicare Part D claims for 188 patients. 54% of them were for generic drugs. CMS names the drug for 1,166 of them, across 22 drugs with 11 or more claims each, at $2,872,946 in total drug cost. In 2023, CMS named 1,139 claims across 26 drugs.

Dr. Padilla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Padilla as offering telehealth.

Dmand AI links 49 papers to Dr. Padilla, published from 2011 to 2025. 2019 was the busiest year, with 6. The most frequent topics are Tomography, X-Ray Computed, Lung and Lung Diseases, Interstitial. Dr. Padilla has published most often in Clin Imaging. Dr. Padilla's most frequent co-authors are Mary M. Salvatore, MD, Kathleen Mary Capaccione, MD, PhD and David F. Yankelevitz, MD.

Dmand AI links Dr. Padilla to 4 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis and Cicatrix.

CMS Open Payments shows 220 general payments to Dr. Padilla from 6 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 46% of the total. Genentech, Inc. paid the most, $130,317.

Dmand AI lists 6 awards for Dr. Padilla, most recently America's Top Doctors in 2014.

Dr. Padilla graduated from Icahn School Of Medicine At Mount Sinai in 1975. Dr. Padilla is a member of ATS.

Dr. Padilla is in network with 13 carriers, including Aetna, United Healthcare and Elevance. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.